Antihypertensive drug use and blood pressure control among stroke survivors in the United States: NHANES 2003-2014.
Adult
Aged
Aged, 80 and over
Angiotensin-Converting Enzyme Inhibitors
/ therapeutic use
Antihypertensive Agents
/ therapeutic use
Blood Pressure
/ drug effects
Blood Pressure Determination
/ methods
Case-Control Studies
Cross-Sectional Studies
Diuretics
/ therapeutic use
Drug Therapy, Combination
Female
Humans
Hypertension
/ complications
Male
Middle Aged
Nutrition Surveys
/ methods
Retrospective Studies
Risk Factors
Self Report
/ statistics & numerical data
Stroke
/ epidemiology
Survivors
/ statistics & numerical data
United States
/ epidemiology
blood pressure
prevalence
secondary prevention
stroke
Journal
Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
22
01
2019
revised:
02
04
2019
accepted:
21
04
2019
pubmed:
18
5
2019
medline:
17
9
2020
entrez:
18
5
2019
Statut:
ppublish
Résumé
Understanding the patterns of antihypertensive drug use and blood pressure (BP) control among stroke survivors in the "real-world" setting is important to identify gaps in treatment and control, if any. The objective of our study was to assess trends and patterns in antihypertensive drug use and BP control among stroke survivors in the United States. We performed a retrospective cross-sectional analysis of the 2003-2014 National Health and Nutrition Examination Survey (NHANES). Stroke and hypertension diagnoses were self-reported. Information regarding the use of antihypertensive drugs was collected during an in-person interview. Measurement of BP was performed by trained medical professionals in mobile examination centers. A total 1244 adult stroke survivors (equating to 6 232 215 stroke survivors nationwide) were identified, of which 956 had hypertension. Antihypertensive drug use increased from 2003 (79.5%) to 2014 (92.2%; P for trend < 0.001). The prevalence of drug use was lower (52%) among survivors aged 20-39 years compared with older age groups. Use of ≥2 antihypertensive drugs was prevalent (63.8%), but diuretics alone or in combination with angiotensin-converting enzyme inhibitors were underutilized (22.4%). More than one-third of the survivors were not at BP goal (ie, BP < 140/90 mm Hg). Males were more likely to attain BP goal than female stroke survivors (odds ratio [OR] = 2.02; 95% CI: 1.34-3.05). Our findings suggest that despite improvements in antihypertensive drug use in the recent years, BP is not adequately controlled in a significant proportion of stroke survivors. Further research focusing on understanding the reasons for unmet BP goal in stroke survivors is needed.
Identifiants
pubmed: 31099465
doi: 10.1111/jch.13553
pmc: PMC8030507
doi:
Substances chimiques
Angiotensin-Converting Enzyme Inhibitors
0
Antihypertensive Agents
0
Diuretics
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
766-773Informations de copyright
©2019 Wiley Periodicals, Inc.
Références
Circulation. 2006 Mar 14;113(10):e409-49
pubmed: 16534023
Circulation. 2012 Oct 23;126(17):2105-14
pubmed: 23091084
Stroke. 2003 Nov;34(11):2741-8
pubmed: 14576382
Circulation. 2016 Jan 26;133(4):447-54
pubmed: 26811276
J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):279-84
pubmed: 19010943
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
J Hypertens. 2011 May;29(5):1005-11
pubmed: 21330934
Lancet. 2002 Dec 14;360(9349):1903-13
pubmed: 12493255
BMC Neurol. 2017 Feb 6;17(1):24
pubmed: 28166784
Hypertension. 2008 Apr;51(4):952-9
pubmed: 18259027
Stroke. 2011 Jan;42(1):227-76
pubmed: 20966421
Hypertension. 2017 Jan;69(1):171-179
pubmed: 27802419
Stroke. 2004 Apr;35(4):1024
pubmed: 15053002
JAMA. 1997 Mar 5;277(9):739-45
pubmed: 9042847
JAMA. 2014 Aug 27;312(8):799-808
pubmed: 25157723
Hypertension. 2015 Jan;65(1):54-61
pubmed: 25399687
Am J Hypertens. 2008 Jul;21(7):789-98
pubmed: 18451806
Hypertension. 2007 Jan;49(1):69-75
pubmed: 17159087
JAMA Cardiol. 2018 Apr 1;3(4):352-353
pubmed: 29466540
JAMA. 2010 May 26;303(20):2043-50
pubmed: 20501926
BMC Neurol. 2018 Sep 21;18(1):153
pubmed: 30241499
J Gend Specif Med. 2001;4(3):10-3, 20
pubmed: 11605350
J Clin Hypertens (Greenwich). 2019 Jun;21(6):766-773
pubmed: 31099465
CMAJ. 2014 May 13;186(8):577-84
pubmed: 24733770